American Ideals Processing: Current Events
FDA Approves Trulicity to Treat Type 2 Diabetes
Type 2 Diabetes is a dreadful chronic condition affecting twenty six million people in the United States. It causes dangerously high glucose levels that can lead to heart disease, blindness, nerve, and kidney damage. On September 18, 2014, the U.S Food and Drug Administration (FDA) approved a new, weekly drug to improve glycemic control (blood sugar levels) within victims of Type 2 Diabetes. Trulicity, also known as dulaglutide, is a hormone that aids in normalizing glucose levels. Manufactured by the Eli Lilly and Company, this drug was tested in six trials, where 3,342 patients with Type 2 Diabetes who took Trulicity had an improvement in their blood sugar levels. Following the release of Trulicity, the FDA is requiring post-marketing studies to evaluate topics such as dosage and safety for Trulicity. Overall, Trulicity seems to be a breakthrough drug with the potential to drastically improve the conditions of millions of people in the United States affected by Type 2 Diabetes.
Liberty and Opportunity
The following article relates to two of the American ideals, one of them being liberty. Typically, patients diagnosed with Type 2 Diabetes follow a strict diet and lifestyle. Since this drug, Trulicity, has been shown to improve blood sugar levels, patients are granted more freedom on how they wish to live their lives. For instance, having improved blood sugar levels may allow a patient to broaden their food choices. The article greatly relates to opportunity as well. With this breakthrough drug, patients have the opportunity to drastically reform their health and condition. Scientists are also given the opportunity to research Trulicity and improve its effectiveness. Finally, with a new drug comes a wider variety of treatments for patients to choose from. This offers patients both the liberty to select a new plan and the opportunity to adjust /revise their current treatment.